SUBSCRIBE
SUBSCRIBE

GSK Bio

NEWS
Small Cambridge Biotech Warp Bio Scores $387M R&D
Business
Bay Area’s Five Prime Promotes COO to CEO, Effective January 1, 2018
After four months of looking, Five Prime Therapeutics has found its new CEO.
October 25, 2017
 · 
2 min read
 · 
Alex Keown
Big Pharmas are Poaching Top Talent From Tech Giants Like Google and LinkedIn
Job Trends
Big Pharmas are Poaching Top Talent From Tech Giants Like Google and LinkedIn
October 13, 2017
 · 
2 min read
Top 4 Companies Making Milan Europe’s Next Biotech Hub
October 10, 2017
 · 
1 min read
For Sale: Pfizer's $3.4 Billion Consumer Healthcare Business
Deals
For Sale: Pfizer’s $3.4 Billion Consumer Healthcare Business
October 10, 2017
 · 
3 min read
3 Biotechs That Could be Taken Out This Quarter
Business
GlaxoSmithKline’s Pharma Chief Lands Job at Chinese PE Firm
October 10, 2017
 · 
3 min read
GlaxoSmithKline Ranked The Worst Run Company In The UK
October 10, 2017
 · 
1 min read
3 Life Science Female Execs Share Their Candid Career Advice
Business
3 Life Science Female Execs Share Their Candid Career Advice
Here are three female biopharma chief executives and what they’ve had to say about their rise to the top.
October 5, 2017
 · 
5 min read
Bay Area's Dynavax Quietly Shops Around Its Almost-Approved Hep B Vaccine
Deals
Bay Area’s Dynavax Quietly Shops Around Its Almost-Approved Hep B Vaccine
October 2, 2017
 · 
2 min read
3 Biotechs That Could be Taken Out This Quarter
New Biotech KaNDy Therapeutics Launches to Replace Hormonal Menopause Treatment
September 27, 2017
 · 
2 min read
Load More
  • 2026 - Best Places to Work - Badge (1).png
JOBS
IN THE PRESS
Press Releases
Spero Therapeutics and GSK Announce PIVOT-PO Phase 3 Study for Tebipenem HBr Stopped Early for Efficacy Following Review by Independent Data Monitoring Committee
May 28, 2025
 · 
9 min read
Press Releases
Vesalius Announces Multi-Target Strategic Alliance with GSK to Develop Breakthrough Treatments for People Afflicted with Parkinson’s Disease
November 12, 2024
 · 
4 min read
Press Releases
Expanded age indication for GSK’s AREXVY, the first respiratory syncytial virus (RSV) vaccine approved in Canada for adults aged 50-59 at increased risk
November 5, 2024
 · 
7 min read
Press Releases
GSK Presents Positive Data for AREXVY, Its Respiratory Syncytial Virus (RSV) Vaccine, Indicating Protection Over Three RSV Seasons
October 8, 2024
 · 
10 min read
Pharm Country
GSK Doubles COiMMUNITY Grant Funding, Launches Patient Resources, as Adult Vaccination Rates Begin to Show Promising Rise
March 7, 2024
 · 
5 min read
Pharm Country
GSK Announces AREXVY, Its Respiratory Syncytial Virus (RSV) Vaccine, Is Now Available at All Major US Retail Pharmacies
August 17, 2023
 · 
6 min read
Deals
BELLUS Health Inc. Calls Special Shareholders’ Meeting in Connection with GSK Acquisition
May 16, 2023
 · 
7 min read
Business
AnaptysBio- and GSK-partnered immuno-oncology agent JEMPERLI (dostarlimab-gxly) meets primary endpoint in Phase 3 RUBY trial in primary advanced or recurrent endometrial cancer
December 2, 2022
 · 
5 min read